Hunterian Medicine

About:

Hunterian Medicine is a biotech company that develops cures for a vast number of genetic diseases where no FDA approved therapies exist.

Website: http://hunterian.com/

Twitter/X: HunterianMed

Top Investors: Cystic Fibrosis Foundation

Description:

Hunterian Medicine is a biotech company that develops cures for a vast number of genetic diseases where no FDA approved therapies exist. It is poised to unleash the full potential of CRISPR. Its patented platform technology solves the CRISPR delivery problem by enabling efficient, on-target delivery through a single adeno-associated virus (AAV). The Company was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$3.78M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)hunterian.com

Founders:

Vinod Jaskula-Ranga

Number of Employees:

1-10

Last Funding Date:

2021-05-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai